Astellas adding ‘off-the-shelf’ stem cell tech in $102.5m acquisition – BioPharma-Reporter.com
BioPharma-Reporter.com |
Astellas adding 'off-the-shelf' stem cell tech in $102.5m acquisition
BioPharma-Reporter.com Once the deal is complete, the Seattle-based stem cell maker will become a subsidiary operating under Astellas' Institute for Regenerative Medicine (AIRM), established in 2016. It will also grant Astellas direct access to Universal Cells' universal … Global Stem Cells Banking Market — Revolutionary Way to Cure Life-Threatening Diseases through Stem Cell Banking … Stem Cell Therapy 2.0 – LI Practice Treats More Chronic Conditions USRM Posts Live Webinar with World Renowned Biohacker |
